Prevalence of mild cognitive impairment in type 2 diabetes mellitus is associated with serum galectin‐3 level

Abstract

Gal3 might be associated with cognitive impairment in type 2 diabetes mellitus, and serum Gal3 level might be a new risk factor of MCI in type 2 diabetes mellitus patients.